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+ cells in the inflamed gut (Zigmond et al., 2012) . Thus, moDCs may lose expression of Ly-6C and acquire expression of Zbtb46 upon differentiation from monocytes (Zigmond et al., 2012) ; alternatively, Ly-6C hi monocytes may help to recruit Zbtb46-expressing DCs. Some have suggested that Ly-6C + moDCs might be indistinguishable from monocyte-derived macrophages and myeloid-derived suppressor cells (Guilliams et al., 2014; Chow et al., 2016) or even from relatively undifferentiated monocytes (Jakubzick et al., 2013) .
Langerhans cells (LCs) are branched, unpigmented, and slowly dividing cells resident in the epidermis with an unresolved relationship to other myeloid subsets (Satpathy et al., 2012b; Guilliams et al., 2014) . They develop from embryonic monocytes and are replenished under inflammatory conditions by progenitors in the blood or BM (Merad et al., 2002; Ginhoux et al., 2006; Hoeffel et al., 2012; Seré et al., 2012) . Like microglia, LCs are unaffected by loss of either the cytokine Flt3L or its receptor Flt3 and instead require IL-34 signaling through M-CSFR (Ginhoux et al., 2006 (Ginhoux et al., , 2009 Kingston et al., 2009; Greter et al., 2012; Wang et al., 2012) . However, like classical DCs and unlike macrophages, activated LCs increase migration to draining LNs (Silberberg-Sinakin et al., 1976) , where they up-regulate expression of genes such as Flt3 and Zbtb46 (Miller et al., 2012;  current systems for conditional gene deletion within mouse macrophage lineages are limited by ectopic activity or low efficiency. In this study, we generated a Mafb-driven cre strain to determine whether any dendritic cells (dcs) identified by Zbtb46-GFP expression originate from a Mafb-expressing population. Lineage tracing distinguished macrophages from classical dcs, neutrophils, and B cells in all organs examined. At steady state, Langerhans cells (Lcs) were lineage traced but also expressed Zbtb46-GFP, a phenotype not observed in any other population. After exposure to house dust mite antigen, Zbtb46-negative cd64 + inflammatory cells infiltrating the lung were substantially lineage traced, but Zbtb46-positive cd64 − cells were not. these results provide new evidence for the unique identity of Lcs and challenge the notion that some inflammatory cells are a population of monocyte-derived dcs. Satpathy et al., 2012b) . LCs that migrate out of human skin explants also express abundant ZBTB46 mRNA (Artyomov et al., 2015) , and depletion of Zbtb46-expressing cells decreases the frequency of LCs among cells that migrate out of mouse skin explants and among cells within mouse draining LNs (Mollah et al., 2014) . In other respects, LC migration at steady state is poorly understood (Kaplan, 2010) , in part because the genetic models used in some studies cannot distinguish LCs from other lineages. For example, a langerin-driven fluorescent reporter developed to track LCs also labels classical DCs in the dermis (Kissenpfennig et al., 2005; Bursch et al., 2007; Ginhoux et al., 2007; Poulin et al., 2007) . Similarly, lineage tracing using LysM-Cre labels DCs in the dermis along with langerin-expressing cells in the draining LN (Jakubzick et al., 2008) . For those reasons, we sought to examine whether a macrophage reporter model could clarify the various origins of Zbtb46-expressing DCs observed in vivo. Currently available systems do not permit conditional gene deletion strictly within macrophage lineages (Abram et al., 2014) . For example, LysM-Cre (Clausen et al., 1999) promotes significant deletion in macrophages and neutrophils, and F4/80-Cre (Schaller et al., 2002) deletes incompletely among macrophage populations (Abram et al., 2014) . CD11c-Cre (Caton et al., 2007) deletes robustly in alveolar macrophages and in classical and plasmacytoid DCs, whereas Cx3cr1-Cre deletes in many subsets of macrophages and classical DCs (Abram et al., 2014) . Thus, we set out to design a new lineagetracing model that would be more faithfully restricted to macrophages to study the overlap between macrophage populations and Zbtb46-expressing DCs.
Maf b lineage tracing to distinguish macrophages from other immune lineages reveals dual identity of Langerhans cells

resuLts And dIscussIon Generation of a Maf b-driven lineage-tracing model
Using principal component analysis to compare gene expression in macrophages and DCs, we proposed that a reporter based on expression of the gene that encodes transcription factor Maf B could distinguish macrophages from DCs (Satpathy et al., 2012b) . In myeloid progenitors, Maf B represses erythroid and DC fate (Kelly et al., 2000; Bakri et al., 2005) . In resident macrophages, Maf B and its paralog c-Maf repress a network of self-renewal genes and are transiently downregulated during cell proliferation (Soucie et al., 2016) . Tumorassociated myeloid cells have been identified as macrophages rather than DCs partly on the basis of Maf b mRNA expression (Franklin et al., 2014) .
We targeted C57BL6/N mouse embryonic stem cells to insert sequences encoding FLAG-tagged mCherry fluorescent protein and Cre recombinase into the endogenous Maf b locus. We used sequences encoding self-cleaving 2A peptides (Ryan et al., 1991; Szymczak-Workman et al., 2012) to separate those exogenous protein-coding sequences from each other and from the endogenous single-exon Maf b coding sequence preserved upstream (Fig. 1) . Our in-frame knock-in targeting strategy was informed by observations that protein synthesis rate and mRNA abundance together explain the vast majority of variation in protein abundance (Schwanhäusser et al., 2011; Li et al., 2014; Jovanovic et al., 2015) . In using 2A peptides that yield almost stoichiometric protein coexpression (Szymczak-Workman et al., 2012) , our aim was to generate an allele that recapitulates the characteristics of wild-type Maf b in transcription and translation.
Our attention to faithful expression of Maf B from the mutated allele was prompted by evidence that Maf bhaploinsufficient mice exhibit subtle defects in hematopoiesis (Sultana et al., 2009 ) and by reports that aberrant expression of that protein can severely decrease viability of the organism. The kreisler (kr) mutation is a radiationinduced chromosomal inversion that separates an intact Maf b transcriptional unit from putative distal enhancer elements (Cordes and Barsh, 1994) . Mice homozygous for the kr mutation rarely survive to sexual maturity and show gross behavioral deficits caused by abnormalities in hindbrain and inner ear development (Hertwig, 1942; Cordes and Barsh, 1994) . In contrast, mice homozygous for our targeted allele (which we call Maf B-mCherry-Cre) survived into adulthood and were reproductively competent. They showed behavior indistinguishable from wild-type littermates, never manifesting the circling or dancing movement disorder observed in kr/kr mice (Hertwig, 1942) . These observations suggest that regulation of the Maf b locus was minimally altered by the in-frame insertion of sequences encoding mCherry and Cre.
To generate lineage-tracing mice, we first crossed Zbtb46-GFP mice (Satpathy et al., 2012a) to R26-stop-YFP mice, which have a loxP-flanked stop sequence upstream of an enhanced YFP gene inserted into the constitutive and ubiquitous Gt(ROSA)26Sor locus (Srinivas et al., 2001) ; we then crossed either those progeny or R26-stop-YFP mice to Maf B-mCherry-Cre mice. In the spleen of lineage-tracing mice, Maf b-mCherry was expressed abundantly in F4/80 + macrophages, and expression of the lineage-tracing marker YFP was found in nearly all F4/80 + macrophages but at background frequency among the classical DC subsets (Fig. 2 A and Fig. S1 A) . In the brain, Maf b-mCherry was detectable in microglia, and YFP expression was found in nearly all such cells ( Fig. 2 B and Fig. S1  B) . In the blood, Maf b-mCherry expression was detectable only faintly (not depicted); however, YFP expression was observed in ∼10% of Ly-6C hi monocytes and ∼40% of Ly-6C lo monocytes ( Fig. 2 C and Fig. S1 C) . In contrast, we observed expression of the lineage-tracing marker YFP at a background frequency ranging from ∼1% to ∼6% in CD45 − cells, B cells, and neutrophils ( Fig. 2 C and Fig. S1 C) , which may reflect some quantity of Maf b expression in the hematopoietic stem cell compartment (Sarrazin et al., 2009 ). We detected no interpretable differences in gene expression between YFP + and YFP − Ly-6C lo monocytes by microarray analysis (Fig. 2 D) , suggesting that together they represent a single incompletely lineage-traced subset. We surmise that the short half-life (∼20 h at steady state) of Ly-6C hi monocytes (Ginhoux and Jung, 2014) accounts for the lack of extensive lineage-tracing activity. Although gene expression microarray data show some up-regulation of the Maf b transcript at the Ly-6C hi monocyte stage (Gautier et al., 2012) , the lineage-tracing marker YFP would be detectable at the same stage only if transcription and translation of Cre, Cre-mediated recombination, and transcription, translation, and maturation of YFP occur significantly within a day's span. By comparison, Ccr2-Cre ERT2 -based lineage tracing marks nearly all Ly-6C hi monocytes, but Ccr2 expression is up-regulated before commitment to the monocyte-macrophage lineage at the macrophage-DC progenitor stage, and lineage tracing is detectable in the common DC progenitor and its progeny (Croxford et al., 2015) .
In the blood, Ly-6C lo YFP + monocytes showed greater intensities of YFP expression than did developing Ly-6C int YFP + monocytes; however, the perceived effect was subtle because the latter population was few in number ( Fig. 2 E) . In the gut lamina propria, Ly-6C hi monocytes differentiate into CD64
hi Ly-6C lo MHC-II + macrophages through intermediary stages in a monocyte waterfall Bain et al., 2014) . We found that those intermediary stages also showed an intermediate frequency and intermediate intensities of YFP expression ( Fig. 2 F and Fig. S1 D) . Because YFP expression is under the control of a constitutive and ubiquitous promoter, these data suggest that cells adopting macrophage identity accumulated increasing concentrations of YFP until a steady-state concentration was reached late during differentiation.
Spleen and small intestinal macrophages express Maf b mRNA more abundantly than do macrophages in nearly any other organ (Gautier et al., 2012) . To broaden our analysis, we used surface markers to identify BM and alveolar macrophages, which express little or no Maf b mRNA (Gautier et al., 2012) . In some tissues, however, characteristic macrophage surface markers such as F4/80 cannot unambiguously distinguish those cells from other populations (Randolph and Merad, 2013) . In the BM, we found that cells with the highest abundance of F4/80 showed substantial lineage tracing ( Small peritoneal macrophages (SPMs) have been found to exhibit some characteristics of DCs, including dendritic morphology and expression of markers such as CD209 (DC-SIGN; Cain et al., 2013; Cassado et al., 2015) . Although SPMs and DCs have been distinguished on the basis of M-CSFR or CD11c expression (Gautier et al., 2012; Cain et al., 2013) , both populations are marked in lineage-tracing systems based on Cx3cr1-Cre or LysM-Cre (Cain et al., 2013) . Using Maf B-mCherry-Cre-based lineage tracing in conjunction with the Zbtb46-GFP reporter allele, we found a population of M-CSFR + classical DCs that lacked expression of YFP ( After excluding those cells, large peritoneal macrophages (LPMs) and most SPMs expressed YFP (Fig. 3 C) , and SPMs and DCs exhibited distinct morphologies (Fig. 3 D) . In concordance with gene expression microarray data (Gautier et al., 2012) , LPMs expressed greater quantities of Maf b-mCherry than did SPMs, and LPMs isolated from mice homozygous for the Maf B-mCherry-Cre allele expressed Maf b mRNA as abundantly as did LPMs isolated from wild-type mice (not depicted).
In the skin-draining LN, cells that express DC-SIGN accumulate within the MHC-II hi compartment after intravenous LPS injection (Cheong et al., 2010) . Those cells express Zbtb46-GFP and fail to accumulate in Flt3L-deficient mice after treatment with LPS (Meredith et al., 2012; Satpathy et al., 2012a) , which suggests that they are a population of classical DCs not derived from monocytes as was initially proposed. After LPS treatment of Maf B-mCherry-Cre-based lineage-tracing mice carrying the Zbtb46-GFP allele, we confirmed that MHC-II hi CD11c + Sirp-α + DC-SIGN + cells in the inguinal LN were uniformly positive for expression of Zbtb46-GFP, but we did not observe expression of YFP in that population above a background frequency ( 
Lcs are Zbtb46-expressing cells marked by Maf b-driven lineage tracing
In the epidermis, expression of the surface marker epithelial cell adhesion molecule (EpCAM) is sufficient to distinguish LCs from classical DCs (Henri et al., 2010) . However, in the skin-draining LN, radioresistant LCs are greatly outnumbered by donor-derived cells within the EpCAM + compartment after reconstitution of irradiated mice using heterologous BM (Henri et al., 2010) . Therefore, we assessed whether dual macrophage and DC characteristics observed in LCs could be explained by population heterogeneity at steady state. Using Maf B-mCherry-Cre-based lineage tracing, we first examined LCs in the inguinal LN. In that tissue, all EpCAM + MHC-II + cells were uniformly positive for expression of both Zbtb46-GFP and YFP, whereas EpCAM − Zbtb46-GFP + DC populations did not show YFP expression above background frequency (Fig. 4 A) . Conversely, we found that almost all Zbtb46-GFP + YFP + cells were positive for expression of EpCAM and MHC-II, whereas cells that did not express both Zbtb46-GFP and YFP also did not express EpCAM (not depicted). These observations suggest that Maf b-expressing cells are the sole source of EpCAM + cells in the skin-draining LN at steady state.
We next examined LCs in the epidermis ( The presence of Zbtb46-GFP in skin LCs was unexpected because a previous study has found that the Zbtb46 transcript is expressed at a similar abundance in skin LCs and splenic plasmacytoid DCs, much less than that in classical DCs (Miller et al., 2012; Satpathy et al., 2012b) , and plasmacytoid DCs do not express detectable Zbtb46-GFP (Satpathy et al., 2012a) . We also used anti-Zbtb46 antibody to compare protein expression in Zbtb46-sufficient (Zbtb46 +/+ ) and Zbtb46-deficient (Zbtb46 gfp/gfp ) epidermal LCs (Fig. 4 C) . Consistent with our earlier observation, we found that epidermal LCs expressed Zbtb46 protein. Thus, LCs are monocyte-derived cells that express Zbtb46 even at the tissue-resident stage.
Ly-6c
+ monocyte-derived cells that infiltrate the lung are maturing macrophages In the lung, administration of house dust mite (HDM) antigen induces an influx of cells that are distinguished from classical DCs by expression of CD64, Ly-6C, and MAR-1 (Plantinga et al., 2013) . There has been disagreement as to whether these cells should be considered moDCs (Plantinga et al., 2013) or simply macrophages . Thus, we used Maf B-mCherry-Cre-based lineage tracing to study the infiltrating population after exposure to HDM antigen ( Fig. 5 and Fig. S2 C) . In the lung and mediastinal LN of HDM antigentreated mice, we found that CD45 + MHC-II + CD11c + CD11b + CD64 + cells did not express Zbtb46-GFP (Fig. 5 , B, D, and E). Instead, we observed a continuum of Ly-6C expression within that population in the lung, with the Ly-6C hi fraction expressing a lower abundance of YFP than did the Ly-6C lo fraction (Fig. 5 B) . Because YFP expression is controlled by a constitutive and ubiquitous promoter, these results favor the interpretation that infiltrating CD45 + MHC-II + CD11c + CD11b + CD64 + cells are progressively adopting a macrophage identity. Collectively, our results demonstrate that the Maf B-mCherry-Cre model is suitable for driving gene deletion specifically in macrophages, sparing deletion in DCs or neutrophils. Maf B is also expressed outside the hematopoietic system, where our model may find additional applications. In the mouse endocrine pancreas, for example, Maf B is expressed in mature α-cells but is also required for β-cell maturation (Artner et al., 2007) . In the kidney, Maf B is required for podocyte foot process formation (Moriguchi et al., 2006) . By using a lineage-tracing system based on Maf B-mCherry-Cre, we found evidence that embryonic monocytes acquire Zbtb46 upon differentiation into LCs. In contrast, we found no evidence of similar cells in other organs at steady state (Fig. 6 ) or in the lung under inflammatory conditions. Instead, cells elicited by HDM antigen could be resolved into either Zbtb46-expressing DCs or CD64 + macrophages. Although we cannot exclude the possibility that Maf b-expressing lineages can give rise to Zbtb46-expressing progeny under conditions not examined here, it appears that LCs may be unique in acquiring these distinctive characteristics of macrophages and DCs.
MAterIALs And Methods Mice
Maf B-mCherry-Cre mice were maintained on the C57BL/6N background by interbreeding or by breeding to C57BL/6NJ mice (stock no. 005304; The Jackson Laboratory). To remove the neomycin resistance cassette, mice were bred to flippase (FLP) knock-in (B6N.129S4-Gt(RO-SA)26Sor tm1(FLP1)Dym /J) mice (stock no. 016226; The Jackson Laboratory) and then interbred to remove the FLP-expressing allele. The resulting strain is available at The Jackson Laboratory (stock no. 029664).
Zbtb46-GFP (B6.129S6(C)-Zbtb46 tm1.1Kmm ) mice were generated by breeding 129S-Zbtb46 tm1Kmm mice (Satpathy et al., 2012a) to B6.C-Tg(CMV-cre)1Cgn/J mice (stock no. 006054; The Jackson Laboratory) to remove the neomycin resistance cassette. Offspring were bred to C57BL/6J mice for at least nine generations (removing the Cre-expressing transgene) and deposited at The Jackson Laboratory (stock no. 027618). R26-stop-YFP (B6.129X1-Gt(ROSA)26Sor tm1(EYFP)Cos /J) mice were purchased from The Jackson Laboratory (stock no. 006148) and crossed to Zbtb46-GFP mice on the C57BL/6 background.
Experiments were performed using age-matched mice between 4 and 22 wk of age. Comparisons of treated mice with untreated mice used littermates for both groups; comparisons of fluorescent samples with nonfluorescent samples used, for the latter group, cells isolated from mice lacking the fluorescent markers of interest that were bred and maintained on the C57BL/6 background in the same facility. All mice were bred and maintained in a specific pathogen-free animal facility according to institutional guidelines and under protocols approved by the Animal Studies Committee of Washington University in St. Louis. Generation of the Maf B-mcherry-cre targeted mutation P2A-FLAG-mCherry, T2A-Cre, and mouse Maf B coding sequences were ligated serially into the pMSCV T2A-GFP retroviral overexpression vector, which was modified from the pMSCV IRES-GFP retroviral overexpression vector (Ranganath et al., 1998) , to yield the pMSCV Maf B-P2A-FLAG-mCherry-T2A-Cre retroviral overexpression vector. Primers used to amplify coding sequences by PCR are listed in Table S1 .
The Maf b 3′-untranslated region (UTR) sequence was amplified from 129S6 genomic DNA using the following primers: 5′-ATT AGA ATT CTT TCT GTG AGT CCT GGC GG-3′ and 5′-ATT AAT CGA TGG GGA CTG CTT TTT TGT ACA AAC TTG TTG CCA GAG AAT GTC CCA AAC-3′. Both the amplified 3′-UTR fragment and pMSCV Maf B-P2A-FLAG-mCherry-T2A-Cre retroviral overexpression vector were digested using EcoRI and ClaI and then ligated together. A Maf B-P2A-FLAG-mCherry-T2A-Cre-UTR fragment was released from the resulting vector by restriction digest using SacII, MluI, and Antarctic phosphatase (New England Biolabs, Inc.), and an ∼3-kb fragment containing Maf b 5′-UTR and upstream sequences was amplified from 129S6 genomic DNA and digested using MluI. The primers used to amplify the latter fragment were: 5′-ATT AAG ATC TGG GGA CAA CTT TGT ATA GAA AAG TTG CGG AGT GTG GTG TTC TCT CT-3′ and 5′-CGT CTT CTC GTT CTC CAG GT-3′. The digested fragments were inserted into the pDONR (P4-P1R) plasmid (Invitrogen) by a modified BP recombination reaction in which incubation at room temperature was followed by addition of a supplemental buffer (10 mM MgCl 2 and 1 mM ATP) and T4 DNA ligase (New England Biolabs, Inc.) and incubation at 16°C for 5.5 h before addition of proteinase K solution to terminate the reaction. That reaction generated pENTR Maf B-P2A-FLAG-mCherry-T2A-Cre-UTR.
A loxP-flanked fragment containing a neomycin resistance gene under the control of the Pgk1 promoter (Pgk1-Neo R ) was released by restriction digest from the pLNTK-targeting vector (Gorman et al., 1996) and ligated into the pENTR lox-Puro vector (Iiizumi et al., 2006) to yield pENTR lox-rNeo, as previously described (Satpathy et al., 2012a) . FLP recognition target (FRT) sites were introduced flanking the Pgk1-Neo R cassette by site-directed mutagenesis using Pfu DNA polymerase (Agilent Technologies) to yield pENTR lox-FRT-rNeo. Flanking loxP sites were removed in a twostep process. First, the loxP/FRT-flanked Pgk1-Neo R cassette was replaced with a synthetic DNA fragment purchased from Integrated DNA Technologies to yield an intermediate pENTR plasmid. Second, the intermediate pENTR plasmid was digested using MfeI-HF (New England Biolabs, Inc.) and BamHI, and then was ligated to a Pgk1-Neo R fragment released from pENTR lox-FRT-rNeo using EcoRI and BamHI. Orientation of the synthetic fragment in the intermediate pENTR plasmid determined orientation of the Pgk1-Neo Homology arms were amplified by PCR from C57BL/6 genomic DNA and the vector backbone was amplified from pDEST DTA-MLS (Iiizumi et al., 2006) using Q5 High-Fidelity DNA polymerase (New England Biolabs, Inc.) and primers listed in Table S2 . A synthetic DNA fragment was purchased from Integrated DNA Technologies incorporating partial mCherry coding sequence, partial Maf b 3′-UTR sequence, and restriction sites for subsequent use. The sequence of the synthetic fragment was: 5′-GAG AGA GAC GCC TAC AAG GTC AAG TGC GAG AAA CTC GCC AAC TCC GGC TTC AGG GAG GCG GGC TCC ACC AGC GAC AGC CCC TCC TCT CCT GAG TTC TTT CTG GTC GAG GGC AGC GGC GCC ACG AAC TTC AGC CTG CTG AAG CAA GCA GGA GAT GTT GAA GAA AAC CCC GGC CCT GAT TAC AAG GAT GAC GAT GAC AAG GTG AGC AAG GGC GAG GAG GAT AAC ATG GCC ATC ATC AAG GAG TTC ATG CGC TTC AAG GTG CAC ATG GAG GGC TCC GTG AAC GGC CAC GAG TTC GAG ATC GAG GGC GAG GGC GAG GGC CGC CCC TAC GAG GGC ACC CAG ACC GCC AAG CTG AAG GTG ACC AAG GGT GGC CCC CTG CCC TTC GCC TGG GAC ATC CTG TCC CCT CAG TTC ATG TAC GGC TCC AAG GCC TAC GTG AAG CAC CCC GCC GAC ATC CCC GAC TAC TTG AAG CTG TCC TTC CCC GAG GGA TTT AAA TGG GAG CGC GTG ATG AAC TTC GAG GAC GGC GGC GTG GTG ACC GTG ACC CAG GAC TCC TCC CTG CAG GAC GGC GAG TTC ATC TAC AAG GTG AAG CTG CGC GGC ACC AAC TGA TGT GGC TCT TCG CCC CCC TCG TCC TTC CCA CTT CAG TTT Figure 6 . A Zbtb46 + population marked by Mafb-driven lineage tracing is found in the skin but not in the spleen, lung, or small intestinal lamina propria at steady state. B220 − cells from spleen samples in Fig. 2 A, CD45 + cells from lung samples in Fig. 3 B, CD45
+ cells from small intestinal lamina propria samples in Fig. 2 F, and CD45 + cells from epidermis samples in Fig. 4 TAA GTT TTG TTG AGG GAA AGC GGC CGC TAA GGG  AGA GAC AGA TGC CGA GAT CCA CAT CGT GCA GGA  GTG TGT CCT TTA TTA TTG TTG GGT CTT GGG GCC  AAA TTG ACA TAC ACA CAC CCA CGA CTG CTC CT-3′. The amplified homology arm fragments, amplified vector backbone fragment, and synthetic fragment were assembled using Gibson Assembly Master Mix (New England Biolabs, Inc.) to yield the first intermediate targeting plasmid.
The first intermediate targeting plasmid was linearized using NotI and Antarctic phosphatase (New England Biolabs, Inc.) and then was used for ligation to an FRT-flanked Pgk1-Neo R fragment released from pENTR FRT-Neo or pENTR FRT-rNeo using NotI and BsrGI (having ensured that the pENTR vector backbone would not interfere with ligation by digesting with NheI and AflII after digesting with NotI and BsrGI). The ligation yielded the second intermediate targeting plasmid.
An ∼1-kb fragment containing a portion of the 3′-UTR sequence was amplified from pENTR Maf B-P2A-FLAG-mCherry-T2A-Cre-UTR using the following primers: 5′-GCT CGA GGA TGG GGA CTG AGA ACT GTG AGT CCT GGC GGGT-3′ and 5′-CTG AAG TGG GAA GGA CGA GG-3′. A fragment containing partial mCherry-T2A-Cre was released from pENTR Maf B-P2A-FLAGmCherry-T2A-Cre-UTR using SbfI-HF and EcoRI-HF (New England Biolabs, Inc.). The second intermediate targeting plasmid was linearized using CspCI and then was assembled with the amplified 3′-UTR fragment and the released mCherry-T2A-Cre fragment using Gibson Assembly Master Mix (New England Biolabs, Inc.) to yield the final targeting plasmid.
The linearized final targeting plasmid was electroporated into JM8.N4 mouse embryonic stem cells (C57BL/6N background; Knockout Mouse Project Repository). After selection with G418 (EMD Millipore), targeted clones were individually picked, expanded, and screened by Southern blot analysis. First, homologous recombination was identified using BamHI-digested genomic DNA and a digoxigenin-labeled 3′-probe amplified using the following primers: 5′-GGC ACC AGG GGA ATC TAG AA-3′ and 5′-ATG CTC CAA GAC AAC GAT GC-3′. Next, homologous recombination was confirmed using SwaI-digested genomic DNA and a digoxigenin-labeled 5′-probe amplified using the following primers: 5′-CGC CTC CTA TGT GCC ATA AA-3′ and 5′-TTT CTC CAA AGC AAG CCC TG-3′.
Targeted clones were injected into blastocysts, and male chimeras were bred to female C57BL/6NJ mice (stock no. 000664; The Jackson Laboratory). Confirmation of germline transmission and determination of progeny genotype were performed by PCR using the following primers: 5′-CGA GAA GAC GCA GCT CAT TC-3′ (common forward), 5′-GAA TAG GGA GTC TGG GCC AG-3′ (wild-type reverse), and 5′-CTT GGT CAC CTT CAG CTT GG-3′ (mutant reverse). The expected sizes of amplicons were 424 bp (mutant) and 219 bp (wild type).
cell preparation Cheek pouch (submandibular) blood samples were collected using Microtainer tubes (BD) with EDTA after venipuncture using a 4-mm Golden Rod Animal lancet (MEDIpoint) per the manufacturer's instructions. Spleen samples were minced and digested in IMDM + 10% FCS (cIMDM) supplemented with 250 µg/ml collagenase B (Roche) and 30 U/ml DNase I (Sigma-Aldrich) for 30 min to 1 h at 37°C with stirring; LN samples were digested in the same manner without mincing. Microglia were isolated from brain by density gradient centrifugation using Percoll (P4937; SigmaAldrich), modifying a previously described method (Lee and Tansey, 2013) by substituting IMDM for DMEM/Nutrient Mixture F-12 (DMEM/F-12) and by additionally supplementing the dissociation medium with 1.7 mg/ml collagenase D (Roche), also omitting papain. In brief, brains were diced, dissociated in medium supplemented with Liberase TM (Roche), washed, filtered, and suspended in 37% Percoll. 70% Percoll was underlaid and 30% Percoll was overlaid. HBSS (Thermo Fisher Scientific) was overlaid, and samples were centrifuged before cells in the interface between 37% Percoll and 70% Percoll were recovered and washed. Peritoneum samples were harvested by injecting 10 ml PBS into the peritoneal cavity, agitating vigorously, and then collecting the injected fluid. BM samples were obtained by flushing the femur (or both the femur and the tibia) with magneticactivated cell-sorting (MACS) buffer (PBS + 0.5% BSA + 2 mM EDTA). Epidermis samples were prepared by splitting ears into dorsal and ventral halves, incubating atop RPMI-1640 medium + 1.25 U/ml dispase (Roche) for 45 min to 1 h at 37°C, peeling and mincing epidermal sheets, and digesting in 0.05% trypsin-EDTA solution (Gibco) for 40 min at 37°C followed by repetitive pipetting. Lung samples were prepared after perfusion by injection of 5-10 ml PBS into the right ventricle; lung lobes were minced and digested in cIMDM supplemented with 2-4 mg/ml collagenase D and 30 U/ml DNase I for 1-2 h at 37°C with stirring. Small intestinal lamina propria samples were prepared as follows: after removal of Peyer's patches and fat, intestines were opened longitudinally, washed of fecal content, cut into pieces 1 cm in length, and incubated in HBSS + 15 mM Hepes + 5 mM EDTA at 37°C for 40 min with shaking at 250 rpm. Tissue suspensions were passed through a sieve, and the tissue pieces remaining were washed twice in PBS, minced, and incubated in cIMDM supplemented with collagenase B, collagenase D, and DNase I for 90 min at 37°C with stirring. Cell suspensions were pelleted, suspended in 40% Percoll, overlaid on 70% Percoll, and centrifuged for 20 min at 850 g before cells in the interface were recovered and washed in PBS.
To remove erythrocytes, samples were treated with ACK lysing buffer (0.15 M NH 4 Cl + 10 mM KHCO 3 + 0.10 mM EDTA). Cells were filtered through 36-µm or 80-µm nylon mesh before resuspension in MACS buffer, and any cell counts were determined using a Vi-CELL analyzer (Beckman Coulter).
Antibodies and flow cytometry
Samples were stained in MACS buffer at 4°C in the presence of Fc Block (2.4G2; BD). The following antibodies purchased from BD, BioLegend, eBioscience, or Tonbo Biosciences were used to detect surface markers by flow cytometry: anti-CD3e (145-2C11) conjugated to biotin or FITC; anti-CD11b (M1/70) conjugated to eFluor 450, Pacific blue, FITC, PE, PE-Cy7, Alexa Fluor (AF) 700, or APC-Cy7; anti-CD11c (N418) conjugated to biotin, PerCP-Cy5.5, AF 647, or APC-Cy7; anti-CD11c (HL3) conjugated to Brilliant Violet 395; anti-CD19 (1D3) conjugated to biotin; anti-CD24 (M1/69) conjugated to PE, PE-Cy7, or AF 647; anti-CD43 (S7) conjugated to APC; anti-CD45 (30-F11) conjugated to eVolve 605; anti-CD45.2 (104) conjugated to Brilliant violet (BV) 605, PerCP-Cy5.5, APC, APC-Cy7, or APC-eFluor 780; anti-CD45R (B220; RA3-6B2) conjugated to eFluor 450, BV 510, PE-Cy7, AF 700, or APC-Cy7; anti-CD62L (MEL-14) conjugated to APC; anti-CD64 (X54-5/7.1) conjugated to AF 647 or APC; anti-CD102 (3C4 [MIC2/4]) conjugated to AF 647; anti-CD103 (M290) conjugated to BV 421; anti-CD115 (M-CSFR; AFS98) conjugated to BV 711, PerCP-eFluor 710, or PE; anti-CD117 (Kit; 2B8) conjugated to APC-eFluor 780; anti-CD135 (Flt3; A2F10) conjugated to APC; anti-CD170 (Siglec-F; E50-2440) conjugated to PE; anti-CD172a (Sirp-α; P84) conjugated to PerCP-eFluor 710, PE-Cy7, or APC; anti-CD207 (langerin; eBioL31) conjugated to biotin or PE; anti-CD226 (10E5) conjugated to PE; anti-CD326 (EpCAM; G8.8) conjugated to APC; anti-FcεRIα (MAR-1) conjugated to biotin; anti-Ly-6C (AL-21) conjugated to AF 700 or APC; anti-Ly-6C (HK1.4) conjugated to APC-eFluor 780; anti-Ly-6G (1A8) conjugated to biotin, BV 510, PerCP-Cy5.5, or PE; anti-NK1.1 (PK136) conjugated to eFluor 450; anti-F4/80 (BM8) conjugated to PE-Cy7 or APC-eFluor 780; anti-TER-119 conjugated to eFluor 450; and anti-MHC-II (I-A/I-E; M5/114.15.2) conjugated to BV 421, Pacific blue, V500, or BV 510. Streptavidin conjugated to eFluor 450 (eBioscience) or to BV 510 (BD) was also used for flow cytometry. To detect intracellular protein, samples were fixed, permeabilized, and washed using a Transcription Factor Buffer set (BD). The following antibody from BD was used after fixation and permeabilization: anti-Zbtb46 (U4-1374) conjugated to PE. Cells were analyzed using a FAC SCanto II or FAC SAria Fusion flow cytometer (BD), and data were analyzed using FlowJo software (Tree Star). All gating strategies incorporated size and doublet discrimination based on forward and side scatter parameters.
Gene expression microarray analysis RNA was isolated from cells using an RNAqueous-Micro kit (Ambion), and target preparation was performed using the GeneChip WT Pico kit (Affymetrix) for hybridization to Mouse Gene 1.0 ST arrays (Affymetrix). Data were normalized, and expression values were modeled using ArrayStar 5 software (DNA STAR). Original microarray data have been deposited in Gene Expression Omnibus under accession no. GSE86596.
For principal component analysis, data were preprocessed using ArrayStar 5 software with robust multiarray average summarization and quantile normalization. Replicates were grouped by sample, and then, mean log-transformed expression values from each replicate group were exported in table format, imported into R software (R Foundation for Statistical Computing), mean-centered by gene, root-mean-square-scaled by sample, transposed, and subjected to principal component analysis computed by singular value decomposition without additional centering or scaling. Scores were plotted in R software.
Microscopy
Peritoneal macrophages and DCs were sorted using a FAC SAria Fusion flow cytometer (BD), concentrated by Cytospin, and stained with Wright-Giemsa stain using the Hema 3 system (Thermo Fisher Scientific). Bright-field images were captured at room temperature with a 40× objective lens using an EVOS FL Auto Imaging system (Invitrogen).
rt-Pcr
For each biological replicate, peritoneum samples were isolated either from mice homozygous for the neomycin resistance cassette-deleted Maf B-mCherry-Cre allele (Maf b cre/ cre ) or from wild-type control mice. Between 1 × 10 5 and 2 × 10 5 LPMs were sorted from each sample using a FAC SAria Fusion flow cytometer (BD), RNA was isolated using an RNAqueous-Micro kit (Ambion) according to the manufacturer's instructions, first-strand cDNA was synthesized using qScript cDNA SuperMix (Quantabio), and quantitative analysis was performed using the LightCycler 480 system (Roche) with Luminaris Color HiGreen qPCR Master Mix (Thermo Fisher Scientific) and the following primer pairs: Maf b coding sequence (Sato-Nishiwaki et al., 2013) , 5′-CGT CCA GCA GAA ACA TCA CC-3′ and 5′-TCG CAC TTG ACC TTG TAG GC-3′; and Hprt1 (PrimerBank ID 7305155a1), 5′-TCA GTC AAC GGG GGA CAT AAA-3′ and 5′-GGG GCT GTA CTG CTT AAC CAG-3′.
LPs
Mice were injected intravenously with 7.5 µg anti-CD209a (DC-SIGN; MMD3) antibody conjugated to eF660 (eBioscience) with or without 5 µg LPS (from Escherichia coli O55:B5; Sigma-Aldrich) diluted in 0.9% sodium chloride to a final volume of 200 µl, and then, inguinal LN samples were prepared 12 h after treatment.
hdM antigen
HDM antigen (Dermatophagoides pteronyssinus extracts; Greer Laboratories) was dissolved in PBS. Mice were sensitized and challenged intratracheally, as outlined in Fig. 5 (A or C) , to induce allergic airway inflammation, and lung and mediastinal LN samples were prepared 2 or 3 d after final challenge.
online supplemental material Fig. S1 and S2 show flow cytometry gating strategies used to identify cell populations analyzed in this study. Tables S1 and   2563 JEM Vol. 213, No. 12 S2 detail primers used in the generation of the Maf B-mCherry-Cre targeting plasmid.
